Sanofi acquires US firm developing kinase inhibitors

Wednesday 30 June 2010

Sanofi-Aventis SA is acquiring TargeGen Inc, a privately held US company that specialises in developing small-molecule kinase inhibitors for treatment of haematological malignancies.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France